Carcinoma, Squamous Cell, Non-small-cell Lung
1 clinical trials · Condition
◉ Watch Carcinoma, Squamous Cell, Non-small-cell Lung
| Record | Firm | Date |
|---|---|---|
| A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008) (NCT03976362) | Merck Sharp & Dohme LLC | 2019-06-28 |
Track Carcinoma, Squamous Cell, Non-small-cell Lung automatically
Every clearance here is in the API, with alerts when new ones post.